E. Rusicke

1.4k total citations
23 papers, 449 citations indexed

About

E. Rusicke is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, E. Rusicke has authored 23 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 15 papers in Hematology and 6 papers in Molecular Biology. Recurrent topics in E. Rusicke's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (22 papers), Hemophilia Treatment and Research (12 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). E. Rusicke is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (22 papers), Hemophilia Treatment and Research (12 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). E. Rusicke collaborates with scholars based in Germany, Italy and United Kingdom. E. Rusicke's co-authors include W. Kreuz, Emel Aygören‐Pürsün, Inmaculada Martinez‐Saguer, Thomas Klingebiel, Christine Heller, I. Martinez‐Saguer, Johannes Oldenburg, Nils von Hentig, C. R. Müller and Arkadius Kocot and has published in prestigious journals such as Blood, Journal of Allergy and Clinical Immunology and American Journal of Obstetrics and Gynecology.

In The Last Decade

E. Rusicke

23 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E. Rusicke Germany	9	413	164	150	149	147	23	449
M. Baş Germany	5	448 1.1×	226 1.4×	129 0.9×	175 1.2×	99 0.7×	7	476
Beáta Visy Hungary	10	563 1.4×	235 1.4×	214 1.4×	209 1.4×	175 1.2×	22	604
György Temesszentandrási Hungary	8	325 0.8×	132 0.8×	103 0.7×	91 0.6×	113 0.8×	11	375
Romualdo Vacchini Italy	7	330 0.8×	174 1.1×	68 0.5×	134 0.9×	74 0.5×	8	349
George Harmat Hungary	6	267 0.6×	104 0.6×	111 0.7×	105 0.7×	79 0.5×	8	290
Sonja Visscher United States	5	250 0.6×	100 0.6×	95 0.6×	92 0.6×	74 0.5×	7	267
Henrike Feuersenger United States	10	198 0.5×	72 0.4×	59 0.4×	53 0.4×	62 0.4×	30	233
G. Martignoni Italy	8	173 0.4×	43 0.3×	82 0.5×	108 0.7×	73 0.5×	24	429
Hilde P.E. Peters Netherlands	8	230 0.6×	24 0.1×	95 0.6×	27 0.2×	294 2.0×	9	420
Ryan Iarrobino United States	6	147 0.4×	54 0.3×	32 0.2×	31 0.2×	35 0.2×	9	181

Countries citing papers authored by E. Rusicke

Since Specialization

Citations

This map shows the geographic impact of E. Rusicke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Rusicke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Rusicke more than expected).

Fields of papers citing papers by E. Rusicke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Rusicke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Rusicke. The network helps show where E. Rusicke may publish in the future.

Co-authorship network of co-authors of E. Rusicke

This figure shows the co-authorship network connecting the top 25 collaborators of E. Rusicke. A scholar is included among the top collaborators of E. Rusicke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Rusicke. E. Rusicke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Martinez‐Saguer, Inmaculada, Jochen Graff, E. Rusicke, et al.. (2013). Does Early Clinical Manifestation of Hereditary Angioedema (HAE) Influence the Clinical Course of the Disease?. Journal of Allergy and Clinical Immunology. 131(2). AB30–AB30. 1 indexed citations

Martinez‐Saguer, Inmaculada, Emel Aygören‐Pürsün, E. Rusicke, Thomas Klingebiel, & W. Kreuz. (2012). 549 Management of Twenty-Five Pediatric Patients with Hereditary Angioedema (Hae) Undergoing Home Treatment—A Clinical Surveillance Program. World Allergy Organization Journal. 5. S174–S174. 1 indexed citations

Kreuz, W., E. Rusicke, Inmaculada Martinez‐Saguer, et al.. (2011). Home therapy with intravenous human C1‐inhibitor in children and adolescents with hereditary angioedema. Transfusion. 52(1). 100–107. 60 indexed citations

Martinez‐Saguer, Inmaculada, Marco Cicardi, Emel Aygören‐Pürsün, et al.. (2011). Pharmacokinetic Berinert P Study Of Subcutaneous Versus Intravenous Administration In Subjects With Moderate Hereditary Angioedema - The Passion Study. Journal of Allergy and Clinical Immunology. 127(2). AB104–AB104. 3 indexed citations

Martinez‐Saguer, Inmaculada, E. Rusicke, Emel Aygören‐Pürsün, et al.. (2010). Characterization of acute hereditary angioedema attacks during pregnancy and breast-feeding and their treatment with C1 inhibitor concentrate. American Journal of Obstetrics and Gynecology. 203(2). 131.e1–131.e7. 79 indexed citations

Aygören‐Pürsün, Emel, Inmaculada Martinez‐Saguer, E. Rusicke, Thomas Klingebiel, & W. Kreuz. (2010). On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience. Allergy Asthma and Clinical Immunology. 6(1). 21–21. 39 indexed citations

Rusicke, E., Inmaculada Martinez‐Saguer, Emel Aygören‐Pürsün, T. Klingebiel, & W. Kreuz. (2010). Short-term Prophylaxis With C1-inhibitor Concentrate In Patients With Hereditary Angioedema Prior To Surgical Procedures. Journal of Allergy and Clinical Immunology. 125(2). AB164–AB164. 3 indexed citations

Martinez‐Saguer, Inmaculada, E. Rusicke, Emel Aygören‐Pürsün, et al.. (2009). Pharmacokinetic analysis of human plasma–derived pasteurized C1‐inhibitor concentrate in adults and children with hereditary angioedema: a prospective study. Transfusion. 50(2). 354–360. 39 indexed citations

Kreuz, W., et al.. (2009). C1‐inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis. Transfusion. 49(9). 1987–1995. 75 indexed citations

10.

Aygören‐Pürsün, Emel, E. Rusicke, Inmaculada Martinez Saguer, & W. Kreuz. (2009). Acquired C1-Inhibitor Deficiency - Report of 18 Cases. Journal of Allergy and Clinical Immunology. 123(2). S13–S13. 5 indexed citations

11.

Kreuz, W., I. Martinez‐Saguer, E. Rusicke, Emel Aygören‐Pürsün, & T. Klingebiel. (2009). Impact Of The Frankfurt HAE Therapy Protocol On Health-Related Quality Of Life (HRQoL) In 50 Patients With Hereditary Angioedema (HAE). Journal of Allergy and Clinical Immunology. 123(2). S116–S116. 2 indexed citations

12.

Kocot, Arkadius, W. Kreuz, I. Martinez‐Saguer, et al.. (2008). Mutational spectrum of the<i> C1INH (SERPING1) </i>gene in patients with hereditary angioedema. Cytogenetic and Genome Research. 121(3-4). 181–188. 63 indexed citations

13.

Kreuz, W., I. Martinez‐Saguer, E. Rusicke, Emel Aygören‐Pürsün, & T. Klingebiel. (2008). Management Of HAE Patients During Pregnancy And Delivery - A Prospective 12-years Follow Up -. Journal of Allergy and Clinical Immunology. 121(2). S98–S98. 2 indexed citations

14.

Rusicke, E., et al.. (2008). Age-related Reference Ranges Of C1-inh Activity And Antigen Are Important For Early Diagnosis In Paediatric Patients With Hereditary Angioedema (hae). Journal of Allergy and Clinical Immunology. 121(2). S99–S99. 1 indexed citations

15.

Rusicke, E., I. Martinez‐Saguer, Emel Aygören‐Pürsün, T. Klingebiel, & W. Kreuz. (2007). Intraindividual And Interindividual Variations Of Symptoms In Patients With Hereditary Angioedema. Journal of Allergy and Clinical Immunology. 119(1). S312–S312. 2 indexed citations

16.

Kreuz, W., Emel Aygören‐Pürsün, Inmaculada Martinez‐Saguer, E. Rusicke, & Thomas Klingebiel. (2007). Adverse Effects of Danazol in the Prophylactic Treatment of Hereditary or Acquired C1-Inhibitor Deficiency. Journal of Allergy and Clinical Immunology. 119(1). S43–S43. 2 indexed citations

17.

Aygören‐Pürsün, Emel, Inmaculada Martinez Saguer, E. Rusicke, et al.. (2006). Retrochorionic hematoma in congenital afibrinogenemia: Resolution with fibrinogen concentrate infusions. American Journal of Hematology. 82(4). 317–320. 20 indexed citations

18.

Martinez‐Saguer, Inmaculada, E. Rusicke, Emel Aygören‐Pürsün, & W. Kreuz. (2006). Individual Replacement Therapy (IRT) with a Pasteurized C1-Inhibitor Concentrate Compared to Prophylaxis with Danazol in Patients with Hereditary Angioedema (HAE) - A Prospective Study. Journal of Allergy and Clinical Immunology. 117(2). S180–S180. 3 indexed citations

19.

Rusicke, E., I. Martinez‐Saguer, Emel Aygören‐Pürsün, & W. Kreuz. (2006). Home Treatment in Patients with Hereditary Angiodema (HAE). Journal of Allergy and Clinical Immunology. 117(2). S180–S180. 8 indexed citations

20.

Kreuz, W., et al.. (2004). Individual Replacement Therapy (IRT) with a Pasteurized C1-Inhibitor Concentrate Compared to Prophylaxis with Danazol in Patients with Hereditary Angioedema (HAE) - a Prospective Study.. Blood. 104(11). 1028–1028. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact